- Home
- Ra Capital Healthcare Fund Lp
Insider Trading History of Ra Capital Healthcare Fund Lp
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ra Capital Healthcare Fund Lp since 2010.
The trader's CIK number is 1315082.
At the time of the last reporting, Ra Capital Healthcare Fund Lp was the 10% Owner of Synthorx, Inc.. (stock ticker symbol THOR).
Also see all insider trading activities at Synthorx, Inc..
Note that in the past
RA Capital Healthcare Fund LP also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Wave Life Sciences Ltd. (WVE) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | WVE | 1,875,000 | $30,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | DRNA | 0 | $0 | 0 | $0 | 2,645,442 | $0 |
2014 | DRNA | 1,000,000 | $15,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Achillion Pharmaceuticals Inc (ACHN) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | ACHN | 0 | $0 | 10,535,000 | $109,854,405 | 0 | $0 |
2013 | ACHN | 9,913,946 | $26,900,008 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Synthorx, Inc. (THOR) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | THOR | 4,545,455 | $50,000,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ACRS | 23,440 | $453,811 | 525,550 | $12,731,097 | 0 | $0 |
2015 | ACRS | 249,610 | $3,494,680 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biospecifics Technologies Corp (BSTC) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | BSTC | 0 | $0 | 215,141 | $6,213,876 | 0 | $0 |
Yearly summary of insider trading at Derma Sciences, Inc. (DSCI) by Ra Capital Healthcare Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | DSCI | 0 | $0 | 300,000 | $3,547,500 | 0 | $0 |
2013 | DSCI | 3,945 | $44,973 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Ra Capital Healthcare Fund Lp:
1. Wave Life Sciences Ltd. (WVE)
2. Dicerna Pharmaceuticals Inc (DRNA)
3. Achillion Pharmaceuticals Inc (ACHN)
4. Synthorx, Inc. (THOR)
5. Aclaris Therapeutics, Inc. (ACRS)
6. Biospecifics Technologies Corp (BSTC)
7. Derma Sciences, Inc. (DSCI)
Table 1. Insider trading of Wave Life Sciences Ltd. (WVE) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-11-16 | WVE | Buy | 1,875,000 | 16.00 | 30,000,000 |
Table 2. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-12-18 | DRNA | Option Ex | 2,645,442 | .00 | 0 |
2014-02-04 | DRNA | Buy | 1,000,000 | 15.00 | 15,000,000 |
Table 3. Insider trading of Achillion Pharmaceuticals Inc (ACHN) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-09-29 | ACHN | Sale | 221,014 | 10.96 | 2,423,197 |
2014-09-30 | ACHN | Sale | 1,111,000 | 10.06 | 11,176,660 |
2014-09-25 | ACHN | Sale | 497,986 | 11.04 | 5,499,259 |
2014-09-26 | ACHN | Sale | 670,000 | 11.06 | 7,408,190 |
2014-09-24 | ACHN | Sale | 1,204,929 | 11.26 | 13,571,115 |
2014-09-19 | ACHN | Sale | 1,164,860 | 11.67 | 13,589,256 |
2014-09-22 | ACHN | Sale | 445,689 | 11.09 | 4,941,799 |
2014-09-23 | ACHN | Sale | 984,522 | 11.08 | 10,905,550 |
2014-08-18 | ACHN | Sale | 1,993,978 | 9.66 | 19,255,845 |
2014-08-15 | ACHN | Sale | 2,241,022 | 9.41 | 21,083,534 |
2013-11-20 | ACHN | Buy | 1,110,000 | 2.57 | 2,848,260 |
2013-10-31 | ACHN | Buy | 1,186,007 | 2.38 | 2,823,882 |
2013-10-14 | ACHN | Buy | 2,369,229 | 2.79 | 6,617,256 |
2013-10-11 | ACHN | Buy | 2,448,710 | 2.55 | 6,244,210 |
2013-09-30 | ACHN | Buy | 2,800,000 | 2.99 | 8,366,400 |
Table 4. Insider trading of Synthorx, Inc. (THOR) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-12-11 | THOR | Buy | 4,545,455 | 11.00 | 50,000,005 |
Table 5. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-09-15 | ACRS | Sale | 351,950 | 24.08 | 8,474,252 |
2016-09-16 | ACRS | Sale | 173,600 | 24.52 | 4,256,845 |
2016-01-15 | ACRS | Buy | 1,800 | 19.86 | 35,742 |
2016-01-19 | ACRS | Buy | 4,200 | 19.88 | 83,479 |
2016-01-20 | ACRS | Buy | 1,803 | 19.88 | 35,849 |
2016-01-13 | ACRS | Buy | 5,543 | 19.97 | 110,677 |
2016-01-12 | ACRS | Buy | 5,941 | 19.12 | 113,585 |
2016-01-11 | ACRS | Buy | 4,153 | 17.93 | 74,479 |
2015-10-29 | ACRS | Buy | 95,000 | 14.00 | 1,330,000 |
2015-10-28 | ACRS | Buy | 149,200 | 14.00 | 2,088,800 |
2015-10-22 | ACRS | Buy | 5,410 | 14.03 | 75,880 |
Table 6. Insider trading of Biospecifics Technologies Corp (BSTC) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-02-26 | BSTC | Sale | 10,000 | 28.83 | 288,300 |
2010-02-23 | BSTC | Sale | 1,005 | 29.34 | 29,486 |
2010-02-22 | BSTC | Sale | 21,303 | 29.01 | 618,000 |
2010-02-17 | BSTC | Sale | 50,000 | 29.05 | 1,452,500 |
2010-02-03 | BSTC | Sale | 132,833 | 28.80 | 3,825,590 |
Table 7. Insider trading of Derma Sciences, Inc. (DSCI) by Ra Capital Healthcare Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-01-10 | DSCI | Sale | 300,000 | 11.82 | 3,547,500 |
2013-04-29 | DSCI | Buy | 3,945 | 11.40 | 44,973 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ra Capital Healthcare Fund Lp
(10% Owner of Synthorx, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.